HDT Bio

📍 Seattle, United States🗓 Founded 2018👥 48 employees💰 Last funded Jul 2021
Biotechnology Research🌐 hdt.bio
Website LinkedIn
HDT Bio Corp. is a biopharmaceutical company developing drugs for immunotherapy of cancers and infectious diseases. Our products are designed to be cost-effective solutions to unmet medical needs and complementary to existing, cutting-edge immunotherapies.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in HDT Bio?
HDT Bio has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did HDT Bio last raise funding?
The most recent investment in HDT Bio recorded on gritt.io was in July 2021.
When was HDT Bio founded?
HDT Bio was founded in 2018.
What industry is HDT Bio in?
HDT Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HDT Bio based?
HDT Bio is headquartered in Seattle, United States.